Danish Forward Pharma A/S has announced the pricing of its initial public offering of 10,500,000 American Depositary Shares, ADSs.
The ADSs represent the biopharmaceutical’s ordinary shares at a price to the public of USD 21.00 per ADS. The share were expected to begin trading on October 15 on the NASDAQ Global Select Market under the ticker symbol “FWP”. Forward Pharma has granted the underwriters a 30-day option to purchase up to an additional 1,575,000 ADSs to cover over-allotments, if any.
Leerink Partners LLC, Jefferies LLC and RBC Capital Markets, LLC are acting as joint book-running managers. JMP Securities LLC is acting as co-manager.